We herein report a peripheral SCC of the lung that presented as a GGN on CT in a patient with pneumoconiosis. Whereas pulmonary adenocarcinoma commonly presents as a GGN, SCC rarely does. The clinical behavior of this variation and appropriate therapeutic strategies remain to be explored.
To our knowledge, four patients with SCC presenting as GGNs have been reported [2,3,4,5]. Peripheral pulmonary SCC most commonly progress by filling alveoli, usually resulting in a well-defined solid nodule in CT images; however, SCC do reportedly rarely spread along the alveolar lumen [6, 7] in a similar manner to the progression of adenocarcinoma in situ. In contrast to adenocarcinomas in situ, which characteristically replace the normal alveolar lining cells, SCC that spread along the alveolar lumen generally form multilayers of tumor cells between the non-neoplastic alveolar epithelial cells and basement membrane [7, 8]. Consistent with previous reports, the tumor cells had spread along the alveolar lumen in the present case (Fig. 1).
The appearance of SCC presenting as GGNs is similar to that of adenocarcinomas presenting as GGNs on CT images. In adenocarcinomas presenting as GGNs, the nodules become larger and their solid components increase over time. The last CT images before operation still showed 64% of the ground glass opacity component in a three-dimensional volumetric analysis [9]. Histologically, the solid components of these GGNs demonstrate stromal invasion, collapsed alveoli, fibrosis, and masses of tumor cells or macrophages that fill the alveolar sacs, whereas in the areas of pure ground glass appearance tumor cells are spread along the alveolar lumen [10]. In the present case, the tumor initially presented as a pure GGN and gradually developed a solid component; the pathological findings were in agreement with these CT findings (Fig. 2). Air-containing spaces or a bubble-like appearance were reportedly noted in one SCC presenting as a GGN, this phenomenon being characteristic of adenocarcinomas presenting as GGNs [2]. In these respects, SCC and adenocarcinoma presenting as GGNs appear similar on CT scans.
Unlike the previously reported cases of SCC presenting as GGNs, the present case is unique in that the patient had underlying pneumoconiosis. In the background lung, fibrosis, silicotic nodules, and macules which are characteristic of pneumoconiosis were identified. Also, focal emphysema was found in the background lung which seemed to secondary to smoking or pneumoconiosis. Pneumoconiosis increases the risk of lung cancer, SCC being the most frequent type of associated lung cancer [11]. Inhalation of carcinogens may play a role in the pathogenesis of lung cancer [12]. It has been reported that SCC arising in patients with pneumoconiosis are significantly more frequently of the peripheral type than those in patients without pneumoconiosis. Peripheral-type SCC also arise preferentially in the lower lobes of patients with pneumoconiosis [11]. In the present case, given that the histologic tumor type was SCC and the tumor arose from a lower lobe, pneumoconiosis may have contributed to its development. SCC should be included in the differential diagnosis of peripherally located GGNs, especially in patients at high risk of SCC of the lung such as those with pneumoconiosis.
Surgical resection, comprising one segmentectomy and three lobectomies, was performed in all four previously reported patients with SCC presenting as GGNs [2,3,4,5]. All these lesions were at an early stage and had good prognoses. In the present case, because the patient had impaired pulmonary function and the tumor was believed to be a ground-glass-dominant adenocarcinoma, we performed segmentectomy. Although sublobar resection is reportedly appropriate in selected patients with such tumors because they are rarely invasive and rarely have lymph node metastases [1], whether sublobar resection for peripheral SCC appearing as GGNs is adequate is unknown. The volume doubling time of the tumor in the present case was about 100 days, whereas the reported volume doubling times of part-solid GGNs that prove to be adenocarcinomas are 276.9–1228.5 days [13,14,15]. This may indicate that the volume doubling times of SCC presenting as GGNs are shorter than those of such adenocarcinomas and that such SCC are potentially more aggressive than those adenocarcinomas. However, there are too few reported cases of SCC presenting as GGNs to draw definite conclusions; more studies are needed to assess their clinicopathological features and determine the most appropriate therapeutic strategies for them.